Zebra Medical Vision presents AI solutions in collaboration with global leaders Philips, Canon Medical Systems US, and Change Healthcare at RSNA

Zebra Medical Vision brings its deep learning medical imaging technology for early detection of osteoporosis, coronary artery disease, intracranial haemorrhage, pneumothorax, and more to the 106th Radiological Society of North America

KIBBUTZ SHEFAYIM, Israel–(BUSINESS WIRE)–#IntelliSpaceZebra Medical Vision, the deep-learning medical imaging analytics company, will be joining the 106th Radiological Society of North America (RSNA) this year, presenting its AI solutions with its global partners for the 6th year in a row. This year, visitors at the Zebra-Med booth will be able to learn about how joined solutions support national scale population screening for early detection of chronic diseases, clinical case studies presenting real world usage value, ROI stories generated, and more. The exhibition will be held virtually from November 29 to December 5.

This year, Zebra-Med is collaborating with Philips IntelliSpace AI to showcase its radiology assistant at the Philips virtual booth, on demand. As part of this collaboration, Philips will also present its picture-archiving and communication system (PACS) together with Zebra-Med’s tech and demonstrate the advantages of a fully seamless AI integration, directly in the radiologists’ workflow.

Zebra-Med’s radiology assistant will also be featured at the booths of Change Healthcare, Intelerad Systems, and Visage.

The work of Zebra-Med and Canon Medical Systems US work will be presented in both companies’ virtual booths, where visitors will be able to find Zebra-Med’s AI embedded with Canon’s solutions. Zebra-Med will also present a case study on triaging pneumothorax findings via chest X-rays, demonstrating the reduction in turnaround time by delivering imaging AI at the point of care.

As for its work with Nuance, visitors will be able to view demonstrations with Nuance’s marketplace integration for intracranial hemorrhage detection and experience Zebra-Med’s Neuro solution offering to alert suspicious cases for prioritization in the marketplace storefront.

“I am thrilled to showcase Zebra-Med’s AI technology alongside global giants at RSNA,” says Ohad Arazi, CEO of Zebra Medical Vision. “The aim has always been to offer the most precise and effective AI-based medical imaging tools through close cooperation with our partners, and we’re achieving that. It’s exciting to be able to demonstrate our success to the world at RSNA.”

To learn more about Zebra-Med’s AI solution in RSNA 2020, visit Zebra-Med’s virtual registration office here.

About Zebra Medical Vision

Zebra Medical Vision’s imaging analytics platform allows healthcare institutions to identify patients at risk of disease and offer improved, preventative treatment pathways, to improve patient care. The company is funded by Khosla Ventures, Marc Benioff, Intermountain Investment Fund, OurCrowd Qure, Aurum, aMoon, Nvidia, J&J and Dolby Ventures. Zebra Medical Vision has raised $52 million in funding to date, and was named a Fast Company Top-5 AI and Machine Learning company. Zebra-Med leads the way in AI FDA cleared products, and is installed in hospitals globally, from Australia to India, Europe to the U.S, and the LATAM region.

Contacts

Media Contact:
Alona Stein

ReBlonde for Zebra Medical Vision

alona@reblonde.com